The relationship between length of Barrett's oesophagus mucosa and body mass index

Alimentary Pharmacology and Therapeutics

Volumn 41, Issue 1, 2015, Pages 137-144

  Abdallah, J ^a   Maradey Romero, C ^a   Lewis, S ^a   Perzynski, A ^a   Fass, R ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BARRETT ESOPHAGUS; BODY MASS; CLINICAL ASSESSMENT; COMORBIDITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPLASIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOSCOPY; ESOPHAGUS MUCOSA; FEMALE; HIATUS HERNIA; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; ORGAN SIZE; RACE DIFFERENCE; SEX DIFFERENCE; SEX RATIO; SMOKING; ALCOHOLISM; ETHNOLOGY; INTESTINE MUCOSA; MIDDLE AGED; PATHOLOGY; RISK; RISK FACTOR; VERY ELDERLY;

GASTROINTESTINAL AGENT;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOLISM; BARRETT ESOPHAGUS; BODY MASS INDEX; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; RISK FACTORS;

EID: 84915781649     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12991     Document Type: Article

References (27)

1. Wang KK, Sampliner RE. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 2008; 103: 788-97.
2. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985; 313: 857-9.
3. Winters C Jr, Spurling TJ, Chobanian SJ, et al. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987; 92: 118-24.
4. Mann NS, Tsai MF, Nair PK. Barrett's esophagus in patients with symptomatic reflux esophagitis. Am J Gastroenterol 1989; 84: 1494-6.
5. Cameron AJ, Kamath PS, Carpenter HA. Prevalence of Barrett's esophagus and intestinal metaplasia at the esophagogastric junction [abstract]. Gastroenterology 1997; 112: AB82.
6. Cook MB, Chow WH, Devesa SS. Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005. Br J Cancer 2009; 101: 855-9.
7. Steevens J, Botterweck AA, Dirx MJ, van den Brandt PA, Schouten LJ. Trends in incidence of oesophageal and stomach cancer subtypes in Europe. Eur J Gastroenterol Hepatol 2010; 22: 669-78.
8. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
9. Oberg S, DeMeester TR, Peters JH, et al. The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure. J Thorac Cardiovasc Surg 1999; 117: 572-80.
10. Fass R, Hell RW, Garewal HS, et al. Correlation of oesophageal acid exposure with Barrett's oesophagus length. Gut 2001; 48: 310-3.
11. Tharalson EF, Martinez SD, Garewal HS, et al. Relationship between rate of change in acid exposure along the esophagus and length of Barrett's epithelium. Am J Gastroenterol 2002; 97: 851-6.
12. Wakelin DE, Al-Mutawa T, Wendel C, Green C, Garewal HS, Fass R. A predictive model for length of Barrett's esophagus with hiatal hernia length and duration of esophageal acid exposure. Gastrointest Endosc 2003; 58: 350-5.
13. Dickman R, Green C, Chey WD, et al. Clinical predictors of Barrett's esophagus length. Gastrointest Endosc 2005; 62: 675-81.
14. Weston AP, Badr AS, Hassanein RS. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol 1999; 94: 3413-9.
15. Corley DA, Kubo A, Levin TR, et al. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology 2007; 133: 34-41; quiz 311.
16. Kamat P, Wen S, Morris J, Anandasabapathy S. Exploring the association between elevated body mass index and Barrett 's esophagus: a systematic review and meta-analysis. Ann Thorac Surg 2009; 87: 655-62.
17. Steevens J, Schouten LJ, Driessen AL, et al. A prospective cohort study on overweight, smoking, alcohol consumption, and risk of Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2011; 20: 345-58.
18. Edelstein ZR, Farrow DC, Bronner MP, Rosen SN, Vaughan TL. Central adiposity and risk of Barrett's esophagus. Gastroenterology 2007; 133: 403-11.
19. Stein DJ, El-Serag HB, Kuczynski J, Kramer JR, Sampliner RE. The association of body mass index with Barrett's oesophagus. Aliment Pharmacol Ther 2005; 22: 1005-10.
20. Ryan AM, Healy LA, Power DG, et al. Barrett esophagus: prevalence of central adiposity, metabolic syndrome, and a proin flammatory state. Ann Surg 2008; 247: 909-15.
21. Fass R. The pathophysiological mechanisms of GERD in the obese patient. Dig Dis Sci 2008; 53: 2300-6.
22. Jacobson BC, Chan AT, Giovannucci EL, Fuchs CS. Body mass index and Barrett's oesophagus in women. Gut 2009; 58: 1460-6.
23. Falk GW, Thota PN, Richter JE, Connor JT, Wachsberger DM. Barrett's esophagus in women: demographic features and progression to high-grade dysplasia and cancer. Clin Gastroenterol Hepatol 2005; 3: 1089-94.
24. Bersentes K, Fass R, Padda S, Johnson C, Sampliner RE. Prevalence of Barrett's esophagus in Hispanics is similar to Caucasians. Dig Dis Sci 1998; 43: 1038-41.
25. Nevill AM, Stewart AD, Olds T, Holder R. Relationship between adiposity and body size reveals limitations of BMI. Am J Phys Anthropol 2006; 129: 151-6.
26. Prentice AM, Jebb SA. Beyond body mass index. Obes Rev 2001; 2: 141-7.
27. Thrift AP, Kramer JR, Alsarraj A, El-Serag HB. Fat mass by bioelectrical impedance analysis is not associated with increased risk of Barrett esophagus. J Clin Gastroenterol 2014; 48: 218-23.